ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesF13.181

F13.181

Billable

Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F13.181 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction.

Key Diagnostic Point:

F13.181 refers to a condition characterized by the abuse of sedative, hypnotic, or anxiolytic substances, leading to significant impairment or distress, particularly manifesting as sexual dysfunction. This code is used when the individual exhibits a pattern of use that results in negative consequences, including but not limited to withdrawal symptoms, tolerance, and continued use despite adverse effects. Sexual dysfunction may present as decreased libido, erectile dysfunction, or other sexual performance issues, which can further complicate the individual's psychological and social well-being. The diagnosis requires careful assessment of the patient's substance use history, the impact on their sexual health, and the presence of any co-occurring mental health disorders. Treatment often involves a multidisciplinary approach, including behavioral therapies, counseling, and possibly pharmacotherapy to manage withdrawal symptoms and address sexual dysfunction.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Requires comprehensive documentation of substance use history.
  • Need to differentiate between primary sexual dysfunction and substance-induced dysfunction.
  • Potential for co-occurring mental health disorders complicating the diagnosis.
  • Variability in symptoms and severity among patients.

Audit Risk Factors

  • Inadequate documentation of substance use history.
  • Failure to document the impact of substance use on sexual function.
  • Misclassification of sexual dysfunction as primary rather than substance-induced.
  • Lack of evidence for treatment interventions provided.

Specialty Focus

Medical Specialties

Psychiatry

Documentation Requirements

Detailed patient history, including substance use patterns and sexual health assessments.

Common Clinical Scenarios

Patients presenting with anxiety or insomnia who misuse sedatives, leading to sexual dysfunction.

Billing Considerations

Consideration of co-occurring mental health disorders and their treatment.

Urology

Documentation Requirements

Assessment of sexual function, including specific tests for erectile dysfunction.

Common Clinical Scenarios

Men presenting with erectile dysfunction who have a history of sedative use.

Billing Considerations

Need for collaboration with mental health providers for comprehensive care.

Coding Guidelines

Inclusion Criteria

Use F13.181 When
  • According to ICD
  • 10 guidelines, F13
  • 181 should be used when there is clear evidence of sedative, hypnotic, or anxiolytic abuse leading to sexual dysfunction
  • Documentation must support the diagnosis, including the nature of the substance use and its impact on sexual health

Exclusion Criteria

Do NOT use F13.181 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

99214CPT Code

Established patient office visit, level 4

Clinical Scenario

Used for follow-up visits for patients with substance use and sexual dysfunction.

Documentation Requirements

Document the patient's substance use history and sexual health assessment.

Specialty Considerations

Psychiatric evaluations may require additional documentation of mental health status.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of substance use disorders, including the differentiation of abuse and dependence, as well as the inclusion of associated conditions like sexual dysfunction, enhancing the accuracy of patient records and treatment plans.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of substance use disorders, including the differentiation of abuse and dependence, as well as the inclusion of associated conditions like sexual dysfunction, enhancing the accuracy of patient records and treatment plans.

Reimbursement & Billing Impact

impact on sexual function, and the treatment plan. Providers should ensure that all relevant details are captured to support the diagnosis and any associated procedures.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Frequently Asked Questions

What is the difference between sedative abuse and dependence?

Sedative abuse refers to the harmful use of sedative substances without meeting the criteria for dependence, while dependence indicates a physical or psychological reliance on the substance, often characterized by tolerance and withdrawal symptoms.